INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Public company

NXLNexalin Technology, Inc.

CIK 0001527352

EDGAR filingsOpen in network
Disclosed transactions6
Buys / sells0 / 0
Max Insider Score21
Connections8with evidence

NXL · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
HB
Hu BenDirector
NXLNexalin Technology, Inc.
Grant or award
A—
100.0K sh
Dec 19, 2025Dec 23, 2025
traded Dec 19, 2025
+4dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 3845 · Electromedical & Electrotherapeutic Apparatus · Nov 4, 2026
  • ← Lobbied forevidence
    RK STRATEGIES, INC.LDA Q1 2026 first quarter · Health issues, Defense, VET · Aug 26, 2026
  • ← Insider ofevidence
    Owens DavidDirector, Chief Medical Officer · Dec 23, 2025
  • ← Insider ofevidence
    Shelton Carolyn HambySr. VP - Quality - Regulatory · Dec 23, 2025
  • ← Insider ofevidence
21
WM
White MarkDirector, CEO
NXLNexalin Technology, Inc.
Grant or award
A
—
1.00M sh
Dec 19, 2025
Dec 23, 2025
traded Dec 19, 2025
+4d
SEC FORM 4

Evidence

21
VJ
Van Fleet JustinCFO
NXLNexalin Technology, Inc.
Grant or award
A—
100.0K sh
Dec 19, 2025Dec 23, 2025
traded Dec 19, 2025
+4dSEC FORM 4

Evidence

21
OD
Owens DavidDirector, Chief Medical Officer
NXLNexalin Technology, Inc.
Grant or award
A—
1.00M sh
Dec 19, 2025Dec 23, 2025
traded Dec 19, 2025
+4dSEC FORM 4

Evidence

21
SH
Shelton Carolyn HambySr. VP - Quality - Regulatory
NXLNexalin Technology, Inc.
Grant or award
A—
100.0K sh
Dec 19, 2025Dec 23, 2025
traded Dec 19, 2025
+4dSEC FORM 4

Evidence

17
KA
Kazden AlanDirector
NXLNexalin Technology, Inc.
Grant or award
A—
100.0K sh
Dec 19, 2025Dec 23, 2025
traded Dec 19, 2025
+4dSEC FORM 4

Evidence

White Mark
Director, CEO · Dec 23, 2025
  • ← Insider ofevidence
    Kazden AlanDirector · Dec 23, 2025
  • ← Insider ofevidence
    Hu BenDirector · Dec 23, 2025
  • ← Insider ofevidence
    Van Fleet JustinCFO · Dec 23, 2025

    • Lobbying

    $40K reported · de-duplicated
    2026 Q2 $20K via firms2026 Q1 $20K via firms
    • RK STRATEGIES, INC.$20K2026 Q1 · posted Aug 26, 2026 · Health issues, Defense, VET
    • RK STRATEGIES, INC.$20K2026 Q2 · posted Aug 26, 2026 · Health issues, Defense, VET

    Connected PAC contributions

    FEC · direct to members

    No contributions from a PAC connected to this company.